Mercury and nickel allergy/ Risk factors in fatigue and autoimmunity Original paper
-
Autoimmune Diseases
Autoimmune Diseases
Autoimmune disease is when the immune system mistakenly attacks the body's tissues, often linked to imbalances in the microbiome, which can disrupt immune regulation and contribute to disease development.
-
Karen Pendergrass
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
What was studied?
This observational study examined the relationship between hypersensitivity to metals—specifically mercury and nickel—and the prevalence of chronic fatigue and autoimmune disorders. The research utilized the MELISA® (Memory Lymphocyte ImmunoStimulation Assay) to assess in vitro lymphocyte reactivity to various metals among patients with autoimmune thyroiditis, fatigue without endocrinopathy, and occupational exposure to dental metals. The central goal was to evaluate whether metal hypersensitivity constitutes a risk factor for fatigue and autoimmunity and whether removal of metal exposures (e.g., dental amalgam) could reverse symptoms.
Who was studied?
The study analyzed 72 fatigued patients divided into three primary groups: (1) 22 patients with autoimmune thyroiditis, including some with autoimmune polyglandular syndrome (APS); (2) 28 fatigued individuals without endocrinopathies, many of whom experienced local or systemic symptoms linked to dental alloys; and (3) 22 fatigued professionals with long-term occupational metal exposure, including dentists and technicians. A control group of 13 healthy, fatigue-free individuals without autoimmunity was also included. Lymphocyte reactivity to 17 metals was measured using the MELISA® test. Additionally, two patients underwent dental amalgam replacement and were followed for symptom changes and immune reactivity post-intervention.
What were the most important findings?
Lymphocyte stimulation indices revealed that reactivity to inorganic mercury and nickel was significantly elevated in all fatigued patient groups compared to healthy controls. Specifically, 72.7% of autoimmune thyroiditis patients and 61.1% reacted to mercury and nickel, respectively, with similar trends in the other fatigued cohorts. This pattern was not seen with most other metals, suggesting a specific immunologic sensitivity to mercury and nickel in this population. Notably, healthy controls exhibited no reactivity to nickel and minimal reactivity to mercury. Two representative case studies illustrated that removal of metal-containing dental restorations significantly reduced both symptom burden and lymphocyte reactivity in follow-up MELISA® tests. One patient, initially disabled due to fatigue and autoimmune comorbidities, returned to work and experienced sustained health improvements after amalgam replacement.
These findings imply a mechanistic link between metal-driven immune activation and chronic fatigue, potentially via inflammatory disruption of the hypothalamic-pituitary-adrenal (HPA) axis. Nickel exposure, often underestimated, appeared especially important, with sensitization possibly enhanced by environmental and occupational exposures (e.g., stainless steel, dental alloys, cigarette smoke). The results further underscore the inadequacy of patch testing alone in detecting systemic hypersensitivity and support the utility of MELISA® as a diagnostic adjunct.
What are the greatest implications of this study?
This paper provides early, compelling evidence that hypersensitivity to mercury and nickel may play a causative role in the symptomatology of fatigue, autoimmune disorders, and related syndromes like chronic fatigue syndrome (CFS). It introduces the concept that these metals can induce systemic immune activation, not merely local contact dermatitis, thereby contributing to dysregulation of the HPA axis and the development or exacerbation of autoimmunity. Clinically, the study supports consideration of metal sensitization in patients with unexplained fatigue or autoimmune disease, and it opens the door to therapeutic strategies involving metal detoxification or elimination—particularly amalgam removal. Furthermore, the study highlights MELISA® testing as a superior method for detecting metal sensitization compared to standard patch tests, particularly in systemic presentations. This work is foundational in drawing attention to metallomic contributors to chronic inflammatory and autoimmune conditions.